Updated:
LYFE Capital Management
LYFE Capital Management is a asset manager based in Grand Cayman, founded 2010; the Altss profile covers its classification, headquarters, registration, AUM...
LYFE Capital Management
LYFE CAPITAL MANAGEMENT LIMITED is an SEC-registered investment adviser in GRAND CAYMAN, registered since 2019. It is based there.
General information
Firm type
Asset Manager
Year founded
2010
Location
Region
Asia
Country
China
City
Grand Cayman
Corporate office
Shanghai, China
Principals
Ben Cherry
Managing Director
Jian Wang
Founder & Managing Partner
Sector focus
Frequently asked questions
What is LYFE Capital Management's primary investment focus?
LYFE Capital Management focuses exclusively on health and life sciences sectors, including biotechnology, medical devices, diagnostics, and healthcare services. The firm invests in both growth equity and buyout transactions.
How does LYFE Capital source proprietary deal flow?
LYFE Capital leverages its Shanghai headquarters and US connections to source cross-border healthcare deals. The firm has deep relationships with Chinese hospital networks, biotech entrepreneurs, and US life sciences advisory firms, allowing it to identify investment opportunities in both markets.
Does LYFE Capital invest in both China and the United States?
Yes, LYFE Capital is one of the few private equity firms headquartered in China that systematically invests in both US and Asian healthcare companies. It has a dedicated US investment team led by Managing Director Ben Cherry (per public record).
What is the typical investment size and stage for LYFE Capital?
LYFE Capital typically targets growth equity and buyout investments ranging from $10 million to $100 million per transaction. The firm focuses on established companies with proven technology or market traction rather than early-stage startups.
How is LYFE Capital related to other Asian healthcare investors?
LYFE Capital operates independently as a Shanghai-based private equity firm. It is not affiliated with any single Chinese corporation or family office but has relationships with institutional investors and family offices in Greater China.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on registered investment advisers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: